PRACTICAL APPLICATIONS OF REFUSE DERIVED FUEL (RDF)JACKSON DV.1981; MATERIALS AND ENERGY FROM REFUSE. INTERNATIONAL SYMPOSIUM. 2/1981/ANTWERP; BEL; ANTWERP: KONINKLIJKE VLAAMSE INGENIEURS-VERENIGING; DA. 1981; PP. 63-76; BIBL. 33 REF.Conference Paper

CYTOTOXIC THRESHOLDS OF VINCRISTINE IN A MURINE AND A HUMAN LEUKEMIA CELL LINE IN VITROJACKSON DV JR; BENDER RA.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 11; PP. 4346-4349; BIBL. 24 REF.Article

LYMPHOGRAPHIC AND ECHOGRAPHIC FINDINGS IN ANGIOIMMUNOBLASTIC LYMPHADENOPATHY.CUNNINGHAM JJ; JACKSON DV JR.1977; ARCH. INTERN. MED.; U.S.A.; DA. 1977; VOL. 137; NO 12; PP. 1693-1695; BIBL. 7 REF.Article

A SENSITIVE RADIOIMMUNOASSAY FOR VINCRISTINE AND VINBLASTINESETHI VS; BURTON SS; JACKSON DV et al.1980; CANCER CHEMOTHER. PHARMACOL.; DEU; DA. 1980; VOL. 4; NO 3; PP. 183-187; BIBL. 14 REF.Article

INTERACTION OF ALBUMIN AND VINCRISTINE WITH A HUMAN LYMPHOBLASTIC LEUKEMIA CELL LINE IN VITROJACKSON DV JR; NICHOLS AP; BENDER RA et al.1980; CANCER BIOCHEM. BIOPHYS.; GBR; DA. 1980; VOL. 4; NO 3; PP. 133-136; BIBL. 14 REF.Article

THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEMOLYTIC-UREMIC SYNDROME IN HLA-IDENTICAL SIBLINGSHELLMAN RM; JACKSON DV; BUSS DH et al.1980; ANN. INTERN. MED.; ISSN 0003-4819; USA; DA. 1980; VOL. 93; NO 2; PP. 283-284; BIBL. 6 REF.Article

UNUSUAL IMMUNOFLUORESCENCE PATTERNS FOR TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE IN BLAST CRISIS CHRONIC MYELOGENOUS LEUKEMIACIBULL ML; COLEMAN MS; HUTTON JJ et al.1981; AM. J. CLIN. PATHOL.; ISSN 0002-9173; USA; DA. 1981; VOL. 75; NO 3; PP. 363-366; BIBL. 20 REF.Article

ADVANCED EPIDERMOID LUNG CANCER: PROLONGED SURVIVAL AFTER CHEMOTHERAPYRICHARDS F II; COOPER MR; WHITE DR et al.1980; CANCER; USA; DA. 1980; VOL. 46; NO 1; PP. 34-37; BIBL. 10 REF.Article

ADRIAMYCIN VERSUS METHOTREXATE IN FIVE-DRUG COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST CANCER: A RANDOMIZED TRIALMUSS HB; WHITE DR; RICHARDS F et al.1978; CANCER; USA; DA. 1978; VOL. 42; NO 5; PP. 2141-2148; BIBL. 21 REF.Article

NONSEMINOMATOUS GERM-CELL CANCER OF THE TESTIS. REDUCING TREATMENT RELATED MORBIDITY IN PATIENTS WITH DISSEMINATED DISEASEPASCHAL BR; MUSS HB; RICHARDS F et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 4; PP. 668-671; BIBL. 9 REF.Article

CHEMOTHERAPY VS. CHEMOIIMMUNOTHERAPY WITH METHANOL EXTRACTION RESIDUE OF BACILLUS CALMETTE-GUERIN (MER) IN ADVANCED BREAST CANCER: A RANDOMIZED TRIAL BY THE PIEDMONT ONCOLOGY ASSOCIATIONMUSS HB; RICHARDS F II; COOPER MR et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 9; PP. 2295-2301; BIBL. 23 REF.Article

CYCLOPHOSPHAMIDE VERSUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL IN ADVANCED PROSTATIC CANCER: A RANDOMIZED TRIALMUSS HB; HOWARD V; RICHARDS F II et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 8; PP. 1949-1953; BIBL. 14 REF.Article

VINCRISTINE, DOXORUBICIN, AND CYCLOPHOSPHAMIDE VERSUS LOW-DOSE INTRAVENOUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL IN ADVANCED BREAST CANCER: A RANDOMIZED TRIAL OF THE PIEDMONT ONCOLOGY ASSOCIATIONMUSS HB; RICHARDS F II; JACKSON DV et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 11; PP. 2269-2274; BIBL. 24 REF.Article

PHARMACOKINETICS OF VINCRISTINE SULFATE IN ADULT CANCER PATIENTSSAGAR SETHI V; JACKSON DV JR; WHITE DR et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 9; PART. 1; PP. 3551-3555; BIBL. 29 REF.Article

INTRAVENOUS VINCRISTINE INFUSION. PHASE I TRIALJACKSON DV JR; SAGAR SETHI V; SPURR CL et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 12; PP. 2559-2564; BIBL. 10 REF.Article

PHARMACOKINETICS OF VINCRISTINE INFUSIONJACKSON DV JR; SAGAR SETHI V; SPURR CL et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1043-1048; BIBL. 15 REF.Article